Topic: Biotech
Dr. Moira Gunn speaks with David Gandcolas from HeartMath, who talks about their simple device which looks at your heartbeat and recognizes stress. On the Bio-Issue of the Week, David Ewing Duncan talks about a breakthrough in prosthetic hands.
In this conversation Jon Udell and Dr. Moira Gunn discuss what it's like for a computer scientist and engineer to venture into the world of biotechnology, why the decade of biotech may finally have arrived, what makes biotech entrepreneurs special, and how we can use Internet media to enlarge the public understanding of science and technology.
Dr. Moira Gunn and David Ewing Duncan interview eminent science writer Matt Ridley, the author of "Genome."
On this special edition of BioTech Nation, Tech Nation host Dr. Moira Gunn reads a chapter from her new book "Welcome to BioTech Nation." Listen to how BioTech Nation got started, her experiences along the way, and how she plunged into the international biotech scene.
While the United States leads the world in biotech, the United Kingdom is a clear second. Dr. Moira Gunn speaks with Malcolm Wicks about the social debate that takes place in the UK about biotech.
Dr. Moira Gunn and David Ewing Duncan report from the international BIO conference. There, they speak with a Parkinson's patient who's undergone an innovative new procedure, and do a conference wrap-up with BIO president, Jim Greenwood.
As part of the Tech Nation series on neuroscience, Dr. Moira Gunn speaks with Dr. Karoly Nikolich, the Executive Director of the Neuroscience Institute at Stanford. They talk about what DNA tells us about our brains.
Billions of dollars have been invested in biotech. Dr. Moira Gunn and David Ewing Duncan weigh those investments against the results produced thus far.
Dr. Moira Gunn speaks with Stephen Hall, the CEO of the New Zealand biotech research & development company Genesis, about what they propose as an alternative to corn for the production of ethanol.
In this series on Neurotech, Dr. Moira Gunn speaks with NeuroInsights' managing director, Casey Lynch, about the definition of this very new and challenging field.
